posaconazole (Noxafil) — Point32Health

Initial criteria

• Patient was started on posaconazole in an inpatient setting OR
• Documented diagnosis of zygomycosis (mucormycosis) OR
• Diagnosis of invasive aspergillosis OR
• Prescribed for prevention of invasive aspergillus and candida fungal infections AND documented diagnosis of hematologic malignancy with neutropenia, or graft-versus-host disease, or hematopoietic stem cell transplant OR
• Documented diagnosis of esophageal candidiasis AND documented failure of or clinical inappropriateness of therapy with at least TWO of the following: oral fluconazole, itraconazole, voriconazole OR
• Documented diagnosis of oropharyngeal candidiasis AND documented failure of or clinical inappropriateness of therapy with all of the following: oral fluconazole AND itraconazole